As described previously, CRISPR-Cas9 mediated EpCAM knockout in FaDu hypopharynx carcinoma cell line showed no notable effect on cell-matrix or cell-cell adhesion [58]. The gene discussed is EPCAM; the disease is hypopharyngeal carcinoma.